137 related articles for article (PubMed ID: 35430389)
1. In vivo analysis of the phosphorylation of tau and the tau protein kinases Cdk5-p35 and GSK3β by using Phos-tag SDS-PAGE.
Hisanaga SI; Krishnankutty A; Kimura T
J Proteomics; 2022 Jun; 262():104591. PubMed ID: 35430389
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
3. Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy.
Kimura T; Sharma G; Ishiguro K; Hisanaga SI
Front Neurosci; 2018; 12():44. PubMed ID: 29467609
[TBL] [Abstract][Full Text] [Related]
4. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
Hallows JL; Chen K; DePinho RA; Vincent I
J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains.
Krishnankutty A; Kimura T; Saito T; Aoyagi K; Asada A; Takahashi SI; Ando K; Ohara-Imaizumi M; Ishiguro K; Hisanaga SI
Sci Rep; 2017 Aug; 7(1):8602. PubMed ID: 28819213
[TBL] [Abstract][Full Text] [Related]
6. Phos-tag diagonal electrophoresis precisely detects the mobility change of phosphoproteins in Phos-tag SDS-PAGE.
Okawara Y; Hirano H; Kimura A; Sato N; Hayashi Y; Osada M; Kawakami T; Ootake N; Kinoshita E; Fujita K
J Proteomics; 2021 Jan; 231():104005. PubMed ID: 33035715
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.
Kimura T; Hosokawa T; Taoka M; Tsutsumi K; Ando K; Ishiguro K; Hosokawa M; Hasegawa M; Hisanaga S
Sci Rep; 2016 Sep; 6():33479. PubMed ID: 27641626
[TBL] [Abstract][Full Text] [Related]
8. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of new ERK substrates by phosphoproteomic technologies including Phos-tag SDS-PAGE.
Yoshikawa H; Nishino K; Kosako H
J Proteomics; 2022 Apr; 258():104543. PubMed ID: 35231659
[TBL] [Abstract][Full Text] [Related]
11. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
Tanaka T; Ohashi S; Takashima A; Kobayashi S
Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
[TBL] [Abstract][Full Text] [Related]
12. Phos-tag-based approach to study protein phosphorylation in the thylakoid membrane.
Nishioka K; Kato Y; Ozawa SI; Takahashi Y; Sakamoto W
Photosynth Res; 2021 Jan; 147(1):107-124. PubMed ID: 33269435
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in Phos-tag electrophoresis for the analysis of phosphoproteins in proteomics.
Hirano H; Shirakawa J
Expert Rev Proteomics; 2022 Feb; 19(2):103-114. PubMed ID: 35285370
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
[TBL] [Abstract][Full Text] [Related]
15. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
16. Physiological and pathological phosphorylation of tau by Cdk5.
Kimura T; Ishiguro K; Hisanaga S
Front Mol Neurosci; 2014; 7():65. PubMed ID: 25076872
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Peroxisome Biogenesis by Phos-Tag SDS-PAGE.
Okumoto K; Fujiki Y
Methods Mol Biol; 2023; 2643():207-215. PubMed ID: 36952188
[TBL] [Abstract][Full Text] [Related]
18. Two-dimensional phosphate-affinity gel electrophoresis for the analysis of phosphoprotein isotypes.
Kinoshita E; Kinoshita-Kikuta E; Matsubara M; Aoki Y; Ohie S; Mouri Y; Koike T
Electrophoresis; 2009 Feb; 30(3):550-9. PubMed ID: 19156764
[TBL] [Abstract][Full Text] [Related]
19. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
20. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
